 | Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Rating Reaffirmed by Aegis
marketbeat.com - February 18 at 6:53 AM |
 | Oramed to Present at H.C. Wainwright Global Life Sciences Conference 2021
finance.yahoo.com - March 4 at 9:29 AM |
 | Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Up 5.2%
americanbankingnews.com - February 24 at 10:38 PM |
| Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Down 11.6%
americanbankingnews.com - February 22 at 10:20 PM |
| Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Reiterated by Aegis
americanbankingnews.com - February 18 at 6:52 AM |
| Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Up 54.8% in January
americanbankingnews.com - February 14 at 12:20 PM |
| Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Up 7.8%
americanbankingnews.com - February 12 at 7:50 PM |
| Oramed Pharmaceuticals (NASDAQ:ORMP) Now Covered by National Securities
americanbankingnews.com - February 9 at 9:15 AM |
| Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study
finance.yahoo.com - January 21 at 12:43 PM |
| We're Hopeful That Oramed Pharmaceuticals (NASDAQ:ORMP) Will Use Its Cash Wisely
finance.yahoo.com - January 8 at 2:21 PM |
|
| Oramed to Present at H.C. Wainwright BioConnect 2021 Conference
finance.yahoo.com - January 7 at 1:18 PM |
| Oramed Reports Positive First in Human Data from Oral Leptin Study
finance.yahoo.com - December 23 at 11:59 AM |
| ORMP: ORMD-0801 in Phase 3 TD2 and NASH Clinical Studies
finance.yahoo.com - December 10 at 6:04 PM |
 | Oramed launches late-stage NASH study with oral insulin
seekingalpha.com - December 4 at 6:28 PM |
| Is Oramed Pharmaceuticals (ORMP) A Good Stock To Buy Now?
finance.yahoo.com - December 4 at 2:07 AM |
| Oramed Initiates Phase 2 NASH Trial of Oral Insulin
finance.yahoo.com - December 2 at 6:01 PM |
 | Thinking about buying stock in Hancock Jaffe, Oramed Pharmaceuticals, Tilray, Hexo Corp, or Arbutus Biopharma?
marketwatch.com - December 1 at 1:16 AM |
| Oramed Pharma screens first patients under its Phase 3 oral insulin trial, shares +8%
seekingalpha.com - November 24 at 12:35 PM |
| Oramed Initiates Phase 3 Trial of Oral Insulin
finance.yahoo.com - November 24 at 12:35 PM |
 | Oramed Pharmaceuticals Inc. Common Stock (ORMP)
nasdaq.com - November 19 at 7:07 PM |
 | Nobel Laureate, Oramed SAB member Prof. Avram Hershko and Oramed CSO Dr. Miriam Kidron to be Featured on Biotalknology Webinar "Oral Delivery of Therapeutic Proteins - Oramed Story" on November 18, 2020
prnewswire.com - November 12 at 8:57 AM |
| Oramed to Present at H.C. Wainwright 6th Annual Israel Conference
finance.yahoo.com - November 10 at 9:13 AM |
| Oramed Pharmaceuticals'(NASDAQ:ORMP) Share Price Is Down 71% Over The Past Three Years.
finance.yahoo.com - November 9 at 1:36 PM |
| Oramed to Present Phase 2b Oral Insulin Data at American Association of Pharmaceutical Scientists 2020 PharmSci 360 Conference
finance.yahoo.com - October 28 at 12:51 PM |
| Oramed CEO Nadav Kidron & Premas Biotech to Host Webinar "The Journey of Oral Insulin: Oramed Story" on Wednesday October 28, 2020
finance.yahoo.com - October 27 at 9:36 AM |
| Oramed updates on Phase 3 oral insulin studies: protocols submitted to FDA
seekingalpha.com - October 16 at 12:49 PM |
| Oramed Issues Shareholder Update on Pivotal Phase 3 Oral Insulin Studies: Protocols Submitted to FDA
finance.yahoo.com - October 16 at 12:49 PM |
| ORMP: Advancing Toward Phase 3 Program For ORMD-0801
finance.yahoo.com - September 22 at 1:34 PM |
| Oramed Pharmaceuticals to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting
finance.yahoo.com - September 21 at 12:27 PM |
| Oramed's Diabetes Market Survey Shows Strong Support for ORMD-0801 Oral Insulin Among Physicians and Patients
prnewswire.com - September 15 at 12:45 PM |
|
| Oramed's Diabetes Market Survey Shows Strong Support for ORMD-0801 Oral Insulin Among Physicians and Patients
finance.yahoo.com - September 15 at 12:45 PM |
| How Much Is Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) CEO Getting Paid?
finance.yahoo.com - August 11 at 4:04 PM |
| Oramed announces successful end of Phase 2 meeting with FDA for oral insulin
seekingalpha.com - July 15 at 1:49 PM |
| Oramed on go with late-stage oral insulin studies
seekingalpha.com - July 15 at 1:49 PM |
| Oramed Reports Positive End of Phase 2 Meeting With the FDA for Oral Insulin
finance.yahoo.com - July 15 at 1:49 PM |
| Insulin in Pill Form Would Be a Bonanza for Oramed
finance.yahoo.com - July 8 at 8:10 PM |
| Oramed Pharmaceuticals EPS beats by $0.10, beats on revenue
seekingalpha.com - July 8 at 3:10 PM |
| ORMP: Positive Takeaways of Preliminary NASH Study Findings
finance.yahoo.com - June 19 at 1:28 PM |
| Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin
finance.yahoo.com - June 15 at 9:52 AM |
| ORMP Oramed Pharmaceuticals Inc. Common Stock
www.nasdaq.com - June 14 at 12:25 AM |
 | The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
www.benzinga.com - June 12 at 8:38 AM |
| Newsflash: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Analysts Have Been Trimming Their Revenue Forecasts
finance.yahoo.com - June 9 at 12:00 PM |
| Oramed Pharmaceuticals Inc. (ORMP): Are Hedge Funds Right About This Stock?
finance.yahoo.com - June 4 at 8:26 PM |
| Will Oramed Pharmaceuticals (NASDAQ:ORMP) Spend Its Cash Wisely?
finance.yahoo.com - May 5 at 5:44 PM |
| Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June
finance.yahoo.com - May 5 at 8:45 AM |
| ORMP: Second quarter financial results; Strengthens Advisory Board; Positive EoP2 meeting with the FDA
finance.yahoo.com - April 14 at 1:18 PM |
| Oramed Patent in Canada Allowed for Oral Delivery of Proteins
finance.yahoo.com - April 7 at 7:45 AM |
| Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19
finance.yahoo.com - April 1 at 3:57 PM |
| Does Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Have A Particularly Volatile Share Price?
finance.yahoo.com - March 30 at 8:14 PM |
| Oramed up 7% premarket on advancement of oral insulin
seekingalpha.com - March 19 at 12:46 PM |
| Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA
finance.yahoo.com - March 19 at 12:46 PM |
